These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 20173208

  • 21. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J, Niehaus M, Korte T.
    Dtsch Med Wochenschr; 2002 Oct 11; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract] [Full Text] [Related]

  • 22. Brain natriuretic peptide as a predictor of sudden cardiac death in patients with myocardial infarction.
    Rashidi A, Adler DS.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1528-9; author reply 1529. PubMed ID: 15464343
    [No Abstract] [Full Text] [Related]

  • 23. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ, Passman R.
    J Am Coll Cardiol; 2009 Nov 24; 54(22):2001-5. PubMed ID: 19926004
    [Abstract] [Full Text] [Related]

  • 24. [ICD-implantation--for which patients is its value for primary prevention secure?].
    Fiek M, Reithmann C, Steinbeck G.
    Dtsch Med Wochenschr; 2006 Sep 29; 131(39):2165-8. PubMed ID: 16991035
    [No Abstract] [Full Text] [Related]

  • 25. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.
    J Cardiovasc Med (Hagerstown); 2007 Apr 29; 8(4):293-9. PubMed ID: 17413310
    [Abstract] [Full Text] [Related]

  • 26. [Heart failure with or without myocardial infarct. Which patient profits from defibrillator?].
    Einecke D.
    MMW Fortschr Med; 2004 Mar 25; 146(13):6. PubMed ID: 15219115
    [No Abstract] [Full Text] [Related]

  • 27. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): rationale, design and specific aims.
    Grönefeld G, Connolly SJ, Hohnloser SH, Defibrillator in Acute Myocardial Infarction Trial investigators.
    Card Electrophysiol Rev; 2003 Dec 25; 7(4):447-51. PubMed ID: 15071273
    [Abstract] [Full Text] [Related]

  • 28. Sudden cardiac death: opportunities for prevention.
    Morgan JM, Cowan JC, Camm AJ, McComb JM.
    Heart; 2006 Jun 25; 92(6):721-3. PubMed ID: 16159972
    [Abstract] [Full Text] [Related]

  • 29. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trial.
    Ottervanger JP, Ramdat Misier AR, Zijlstra F, Schalij MJ, Wever E, Jordaens LJ, Henriques JP, de Boer MJ, Robbe HW, Wellens HJ, DAPA Investigators.
    Am Heart J; 2006 Oct 25; 152(4):636-40. PubMed ID: 16996827
    [Abstract] [Full Text] [Related]

  • 30. The confirmatory trial in comparative-effectiveness research.
    Garber AM, Hlatky MA.
    N Engl J Med; 2009 Oct 08; 361(15):1498-9. PubMed ID: 19812407
    [No Abstract] [Full Text] [Related]

  • 31. Tincture of time: when to implant a prophylactic cardioverter-defibrillator following coronary revascularization?
    Gillis AM.
    J Am Coll Cardiol; 2006 May 02; 47(9):1818-9. PubMed ID: 16682306
    [No Abstract] [Full Text] [Related]

  • 32. Selecting patients for an implantable cardioverter-defibrillator: can the genie be put back into the bottle?
    Mittal S.
    J Am Coll Cardiol; 2008 Jan 22; 51(3):297-9. PubMed ID: 18206739
    [No Abstract] [Full Text] [Related]

  • 33. Prevention of sudden cardiac death.
    Goldberger JJ.
    Heart Dis; 2000 Jan 22; 2(4):305-13. PubMed ID: 11728274
    [Abstract] [Full Text] [Related]

  • 34. Is there new hope for sudden cardiac death prevention early after myocardial infarction?
    Stecker EC.
    Heart Rhythm; 2010 Nov 22; 7(11):1598-9. PubMed ID: 20727422
    [No Abstract] [Full Text] [Related]

  • 35. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ, Leman RB.
    Crit Care Nurs Clin North Am; 2005 Mar 22; 17(1):33-8, x. PubMed ID: 15749399
    [Abstract] [Full Text] [Related]

  • 36. To the editor--ICD implantation early after myocardial infarction.
    Selvaraj R, Nair K.
    Heart Rhythm; 2011 Jan 22; 8(1):e1; author reply e2. PubMed ID: 21034857
    [No Abstract] [Full Text] [Related]

  • 37. Implanted cardioverter defibrillators for the prevention of sudden death.
    Dorian P, Talajic M, Tang A.
    Can J Cardiol; 2005 May 22; 21 Suppl A():31A-36A. PubMed ID: 15953942
    [Abstract] [Full Text] [Related]

  • 38. Lessons from a population: the limitations of left ventricular ejection fraction as the major determinant for primary prevention implantable cardioverter-defibrillators.
    Groh WJ.
    J Am Coll Cardiol; 2006 Mar 21; 47(6):1167-8. PubMed ID: 16545647
    [No Abstract] [Full Text] [Related]

  • 39. Aborted sudden death in a patient with a structurally normal heart: the Brugada syndrome.
    Scherr D, Brunner G, Kaufmann P, Lercher P, Lueger A, Rotman B, Smolle KH, Stark G, Klein W, Krejs GJ.
    Intensive Care Med; 2002 Jun 21; 28(6):789-92. PubMed ID: 12107687
    [Abstract] [Full Text] [Related]

  • 40. [Cardiology 2010. New prospects in cardiology].
    Inama G.
    G Ital Cardiol (Rome); 2010 Oct 21; 11(10 Suppl 1):3S-4S. PubMed ID: 21416817
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.